Scientific Presentations

AMELI-01:Preliminary Results from A Phase I Trial of UCART123v1.2, an Anti-CD123 Allogeneic CAR-T Cell Product, in Adult Patients with Relapsed or Refractory (R/R) CD123+ Acute Myeloid Leukemia- ASH 2022- Oral Presentation

Download the PDF file

Preclinical Activity of Allogeneic CS1-Specific CAR T-Cells (UCARTCS1) in Multiple Myeloma - ASH 2022 - Poster Presentation

Download the PDF file

TALEN®-edited smart CAR T-cells leverage solid tumor microenvironment for specific and effective immunotherapy - SITC 2022- Poster Presentation

Download the PDF file

Multi-armored allogeneic MUC-1 CAR T-cells efficiently control triple negative breast cancer tumor growth- SITC 2022- Poster Presentation

Download the PDF file

TALEN®-edited SMART CAR T-cells leverage solid tumor microenvironment for specific and effective immunotherapy- ENA 2022- Poster Presentation

Download the PDF file

Non-viral DNA delivery associated to TALEN® gene editing leads to highly efficient correction of sickle cell mutation in long-term repopulating hematopoietic stem cells- ESGCT 2022- Oral Presentation

Download the PDF file

Non-viral DNA delivery associated to TALEN® gene editing leads to highly efficient correction of sickle cell mutation in long-term repopulating hematopoietic stem cells- ESGCT 2022- Abstract

Download the PDF file

TALEN®-mediated engineering of HSPC enables systemic delivery of IDUA - ESGCT 2022- Abstract

Download the PDF file

TALEN®-mediated engineering of HSPC enables systemic delivery of IDUA- ESGCT 2022- Poster Presentation

Download the PDF file

COMY Presentation - The 8th world Congress on Controversies in Multiple Myeloma

Watch the video